Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

1.

Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2.

Estanga A, Rodriguez-Oroz MC, Ruiz-Martinez J, Barandiaran M, Gorostidi A, Bergareche A, Mondragon E, Lopez de Munain A, Marti-Masso JF.

Parkinsonism Relat Disord. 2014 Oct;20(10):1097-100. doi: 10.1016/j.parkreldis.2014.07.005. Epub 2014 Jul 30.

PMID:
25127457
2.

Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2.

Ruiz-Martínez J, de la Riva P, Rodríguez-Oroz MC, Mondragón Rezola E, Bergareche A, Gorostidi A, Gago B, Estanga A, Larrañaga N, Sarasqueta C, López de Munain A, Martí Massó JF.

Mov Disord. 2014 May;29(6):750-5. doi: 10.1002/mds.25778. Epub 2013 Dec 19.

PMID:
24357540
3.

Lewy bodies under atomic force microscope.

Tercjak A, Bergareche A, Caballero C, Tuñon T, Linazasoro G.

Ultrastruct Pathol. 2014 Feb;38(1):1-5. doi: 10.3109/01913123.2013.825689. Epub 2013 Oct 17.

PMID:
24134525
4.

The ACMSD gene, involved in tryptophan metabolism, is mutated in a family with cortical myoclonus, epilepsy, and parkinsonism.

Martí-Massó JF, Bergareche A, Makarov V, Ruiz-Martinez J, Gorostidi A, López de Munain A, Poza JJ, Striano P, Buxbaum JD, Paisán-Ruiz C.

J Mol Med (Berl). 2013 Dec;91(12):1399-406. doi: 10.1007/s00109-013-1075-4. Epub 2013 Aug 20.

5.

Αlpha-synuclein levels in blood plasma from LRRK2 mutation carriers.

Gorostidi A, Bergareche A, Ruiz-Martínez J, Martí-Massó JF, Cruz M, Varghese S, Qureshi MM, Alzahmi F, Al-Hayani A, López de Munáin A, El-Agnaf OM.

PLoS One. 2012;7(12):e52312. doi: 10.1371/journal.pone.0052312. Epub 2012 Dec 27.

6.

Medical, environmental and personal factors of disability in the elderly in Spain: a screening survey based on the International Classification of Functioning.

Virués-Ortega J, de Pedro-Cuesta J, del Barrio JL, Almazan-Isla J, Bergareche A, Bermejo-Pareja F, Fernández-Mayoralas G, García FJ, Garre-Olmo J, Gascon-Bayarri J, Mahillo I, Martínez-Martín P, Mateos R, Rodríguez F, Rojo-Pérez F, Avellanal F, Saz P, Seijo-Martínez M; Spanish Epidemiological Study Group on Aging.

Gac Sanit. 2011 Dec;25 Suppl 2:29-38. doi: 10.1016/j.gaceta.2011.07.021. Epub 2011 Nov 15.

7.

Sleep disorders in Parkinson disease.

Iranzo de Riquer A, Bergareche A, Campos V.

Neurologist. 2011 Nov;17(6 Suppl 1):S38-42. doi: 10.1097/NRL.0b013e31823966f8. Review.

PMID:
22045324
8.

Exome sequencing identifies GCDH (glutaryl-CoA dehydrogenase) mutations as a cause of a progressive form of early-onset generalized dystonia.

Marti-Masso JF, Ruiz-Martínez J, Makarov V, López de Munain A, Gorostidi A, Bergareche A, Yoon S, Buxbaum JD, Paisán-Ruiz C.

Hum Genet. 2012 Mar;131(3):435-42. doi: 10.1007/s00439-011-1086-6. Epub 2011 Sep 13.

PMID:
21912879
9.

Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations.

Ruiz-Martínez J, Gorostidi A, Goyenechea E, Alzualde A, Poza JJ, Rodríguez F, Bergareche A, Moreno F, López de Munain A, Martí Massó JF.

Mov Disord. 2011 Sep;26(11):2026-31. doi: 10.1002/mds.23773. Epub 2011 May 24.

PMID:
21611983
10.

Prevalence of disability in a composite ≥75 year-old population in Spain: a screening survey based on the International Classification of Functioning.

Virués-Ortega J, de Pedro-Cuesta J, Seijo-Martínez M, Saz P, Sánchez-Sánchez F, Rojo-Pérez F, Rodríguez F, Mateos R, Martínez-Martín P, Mahillo I, Gascon-Bayarri J, Garre-Olmo J, García FJ, Fernández-Mayoralas G, Bermejo-Pareja F, Bergareche A, Almazan-Isla J, del Barrio JL.

BMC Public Health. 2011 Mar 23;11:176. doi: 10.1186/1471-2458-11-176.

11.

[Parkinsonism induced by sulpiride and veralipride: two different stories].

Martí Massó JF, Ruiz-Martínez J, Bergareche A, López de Munain A.

Med Clin (Barc). 2011 Oct 15;137(10):473-4. doi: 10.1016/j.medcli.2010.09.038. Epub 2011 Feb 4. Spanish. No abstract available.

PMID:
21295788
12.

Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain).

Ruiz-Martínez J, Gorostidi A, Ibañez B, Alzualde A, Otaegui D, Moreno F, López de Munain A, Bergareche A, Gómez-Esteban JC, Martí Massó JF.

Mov Disord. 2010 Oct 30;25(14):2340-5. doi: 10.1002/mds.23278.

PMID:
20721916
13.

Prevalence and European comparison of dementia in a ≥75-year-old composite population in Spain.

Virués-Ortega J, de Pedro-Cuesta J, Vega S, Seijo-Martínez M, Saz P, Rodríguez F, Rodríguez-Laso A, Reñé R, de Las Heras SP, Mateos R, Martínez-Martín P, Mahillo-Fernández I, López-Pousa S, Lobo A, Reglà JL, Gascón J, García FJ, Fernández-Martínez M, Boix R, Bermejo-Pareja F, Bergareche A, Sánchez-Sánchez F, de Arce A, del Barrio JL; Spanish Epidemiological Studies on Ageing Group.

Acta Neurol Scand. 2011 May;123(5):316-24. doi: 10.1111/j.1600-0404.2010.01398.x.

PMID:
20636450
14.

What contributes to driving ability in Parkinson's disease.

Cubo E, Martinez Martin P, Gonzalez M, Bergareche A, Campos V, Fernández JM, Alvárez M, Bayes A; Elep Group.

Disabil Rehabil. 2010;32(5):374-8. doi: 10.3109/09638280903168507.

PMID:
19958153
15.

"Frontotemporoparietal" dementia: clinical phenotype associated with the c.709-1G>A PGRN mutation.

Moreno F, Indakoetxea B, Barandiaran M, Alzualde A, Gabilondo A, Estanga A, Ruiz J, Ruibal M, Bergareche A, Martí-Massó JF, López de Munain A.

Neurology. 2009 Oct 27;73(17):1367-74. doi: 10.1212/WNL.0b013e3181bd82a7.

PMID:
19858458
16.

Prevalence of dementia and major dementia subtypes in Spanish populations: a reanalysis of dementia prevalence surveys, 1990-2008.

de Pedro-Cuesta J, Virués-Ortega J, Vega S, Seijo-Martínez M, Saz P, Rodríguez F, Rodríguez-Laso A, Reñé R, de las Heras SP, Mateos R, Martínez-Martín P, Manubens JM, Mahillo-Fernandez I, López-Pousa S, Lobo A, Reglà JL, Gascón J, García FJ, Fernández-Martínez M, Boix R, Bermejo-Pareja F, Bergareche A, Benito-León J, de Arce A, del Barrio JL.

BMC Neurol. 2009 Oct 19;9:55. doi: 10.1186/1471-2377-9-55.

17.

[Tremor: update and controversy].

Ruiz-Martínez J, Arratibel-Echarren I, Gorostidi-Pagola A, Bergareche A, Martí-Massó JF.

Rev Neurol. 2009 Jan 23;48 Suppl 1:S37-41. Review. Spanish.

18.

Wired for autonomy.

da Rocha AC, Bergareche AM.

Am J Bioeth. 2008 May;8(5):23-5; discussion W1-3. doi: 10.1080/15265160802180042. No abstract available.

PMID:
18642192
19.

Mutations in progranulin gene: clinical, pathological, and ribonucleic acid expression findings.

López de Munain A, Alzualde A, Gorostidi A, Otaegui D, Ruiz-Martínez J, Indakoetxea B, Ferrer I, Pérez-Tur J, Sáenz A, Bergareche A, Barandiarán M, Poza JJ, Zabalza R, Ruiz I, Urtasun M, Fernández-Manchola I, Olasagasti B, Espinal JB, Olaskoaga J, Ruibal M, Moreno F, Carrera N, Martí Massó JF.

Biol Psychiatry. 2008 May 15;63(10):946-52. Epub 2007 Oct 22.

PMID:
17950702
20.

[Prevalence of vascular risk factors among Spanish populations aged 70 years and over, as reported in door-to-door studies on neurological diseases].

del Barrio JL, Medrano MJ, Arce A, Bergareche A, Bermejo F, Díaz J, Gascón J, García FJ, Garré J, Gómez C, Lobo A, Martínez A, Otero A, Reñé R, Sánchez MI, Saz P, Vega S, Vilalta-Franch J, Zunzunegui MV, de Pedro J.

Neurologia. 2007 Apr;22(3):138-46. Spanish.

PMID:
17364251
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk